ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)

ClinicalTrials.gov ID: NCT05354141

Public ClinicalTrials.gov record NCT05354141. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 11:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles for Hospitalized Patients With Moderate-to-Severe ARDS: A Phase III Clinical Trial

Study identification

NCT ID
NCT05354141
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Direct Biologics, LLC
Industry
Enrollment
970 participants

Conditions and interventions

Interventions

  • ExoFlo Biological
  • Intravenous normal saline Other

Biological · Other

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2022
Primary completion
Nov 29, 2027
Completion
Dec 30, 2027
Last update posted
Feb 22, 2026

2022 – 2027

United States locations

U.S. sites
32
U.S. states
20
U.S. cities
32
Facility City State ZIP Site status
Direct Biologics Investigational Site Phoenix Arizona 85012 Recruiting
Direct Biologics Investigational Site Little Rock Arkansas 72205 Recruiting
Direct Biologics Investigational Site Davis California 95817 Recruiting
Direct Biologics Investigational Site Irvine California 92627 Recruiting
Direct Biologics Investigational Site Sacramento California 95817 Recruiting
Direct Biologics Investigational Site Washington D.C. District of Columbia 20010 Recruiting
Direct Biologics Investigational Site Jacksonville Florida 32224 Recruiting
Direct Biologics Investigational Site Boise Idaho 83712 Recruiting
Direct Biologics Investigational Site Iowa City Iowa 52242 Recruiting
Direct Biologics Investigational Site Silver Spring Maryland 20910 Recruiting
Direct Biologics Investigational Site Boston Massachusetts 02115 Recruiting
Direct Biologics Investigational Site Burlington Massachusetts 01805 Recruiting
Direct Biologics Investigational Site Springfield Massachusetts 01199 Recruiting
Direct Biologics Investigational Site Detroit Michigan 48202 Recruiting
Direct Biologics Investigational Site Rochester Minnesota 55905 Recruiting
Direct Biologics Investigational Site Jackson Mississippi 39202 Recruiting
Direct Biologics Investigational Site Flushing New York 11368 Recruiting
Direct Biologics Investigational Site Queens New York 11040 Recruiting
Direct Biologics Investigational Site The Bronx New York 10467 Recruiting
Direct Biologics Investigational Site Durham North Carolina 27710 Recruiting
Direct Biologics Investigational Site Winston-Salem North Carolina 27157 Recruiting
Direct Biologics Investigational Site Cincinnati Ohio 45219 Recruiting
Direct Biologics Investigational Site Cleveland Ohio 44106 Recruiting
Direct Biologics Investigational Site Portland Oregon 97239 Recruiting
Direct Biologics Investigational Site Charleston South Carolina 29425 Recruiting
Direct Biologics Investigational Site Knoxville Tennessee 37996 Recruiting
Direct Biologics Investigational Site Nashville Tennessee 37235 Recruiting
Direct Biologics Investigational Site Dallas Texas 75246 Recruiting
Direct Biologics Investigational Site Fort Worth Texas 76104 Recruiting
Direct Biologics Investigational Site Houston Texas 77030 Recruiting
Direct Biologics Investigational Site Murray Utah 84107 Not yet recruiting
Direct Biologics Investigational Site Salt Lake City Utah 84101 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05354141, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 22, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05354141 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →